193 related articles for article (PubMed ID: 38216614)
1. MedGAN: optimized generative adversarial network with graph convolutional networks for novel molecule design.
Macedo B; Ribeiro Vaz I; Taveira Gomes T
Sci Rep; 2024 Jan; 14(1):1212. PubMed ID: 38216614
[TBL] [Abstract][Full Text] [Related]
2. The power of deep learning to ligand-based novel drug discovery.
Baskin II
Expert Opin Drug Discov; 2020 Jul; 15(7):755-764. PubMed ID: 32228116
[TBL] [Abstract][Full Text] [Related]
3. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
[TBL] [Abstract][Full Text] [Related]
4. Generative chemistry: drug discovery with deep learning generative models.
Bian Y; Xie XQ
J Mol Model; 2021 Feb; 27(3):71. PubMed ID: 33543405
[TBL] [Abstract][Full Text] [Related]
5. Generative machine learning for de novo drug discovery: A systematic review.
Martinelli DD
Comput Biol Med; 2022 Jun; 145():105403. PubMed ID: 35339849
[TBL] [Abstract][Full Text] [Related]
6. STAGAN: An approach for improve the stability of molecular graph generation based on generative adversarial networks.
Zou J; Yu J; Hu P; Zhao L; Shi S
Comput Biol Med; 2023 Dec; 167():107691. PubMed ID: 37976819
[TBL] [Abstract][Full Text] [Related]
7. Network-principled deep generative models for designing drug combinations as graph sets.
Karimi M; Hasanzadeh A; Shen Y
Bioinformatics; 2020 Jul; 36(Suppl_1):i445-i454. PubMed ID: 32657357
[TBL] [Abstract][Full Text] [Related]
8. DNMG: Deep molecular generative model by fusion of 3D information for de novo drug design.
Song T; Ren Y; Wang S; Han P; Wang L; Li X; Rodriguez-Patón A
Methods; 2023 Mar; 211():10-22. PubMed ID: 36764588
[TBL] [Abstract][Full Text] [Related]
9. Deep Convolutional Generative Adversarial Network (dcGAN) Models for Screening and Design of Small Molecules Targeting Cannabinoid Receptors.
Bian Y; Wang J; Jun JJ; Xie XQ
Mol Pharm; 2019 Nov; 16(11):4451-4460. PubMed ID: 31589460
[TBL] [Abstract][Full Text] [Related]
10. Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities.
Gangwal A; Ansari A; Ahmad I; Azad AK; Kumarasamy V; Subramaniyan V; Wong LS
Front Pharmacol; 2024; 15():1331062. PubMed ID: 38384298
[TBL] [Abstract][Full Text] [Related]
11. Multi-objective de novo drug design with conditional graph generative model.
Li Y; Zhang L; Liu Z
J Cheminform; 2018 Jul; 10(1):33. PubMed ID: 30043127
[TBL] [Abstract][Full Text] [Related]
12. MedGAN: An adaptive GAN approach for medical image generation.
Guo K; Chen J; Qiu T; Guo S; Luo T; Chen T; Ren S
Comput Biol Med; 2023 Sep; 163():107119. PubMed ID: 37364533
[TBL] [Abstract][Full Text] [Related]
13. druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico.
Kadurin A; Nikolenko S; Khrabrov K; Aliper A; Zhavoronkov A
Mol Pharm; 2017 Sep; 14(9):3098-3104. PubMed ID: 28703000
[TBL] [Abstract][Full Text] [Related]
14. Training recurrent neural networks as generative neural networks for molecular structures: how does it impact drug discovery?
D'Souza S; Kv P; Balaji S
Expert Opin Drug Discov; 2022 Oct; 17(10):1071-1079. PubMed ID: 36216812
[TBL] [Abstract][Full Text] [Related]
15. Generative Models for De Novo Drug Design.
Tong X; Liu X; Tan X; Li X; Jiang J; Xiong Z; Xu T; Jiang H; Qiao N; Zheng M
J Med Chem; 2021 Oct; 64(19):14011-14027. PubMed ID: 34533311
[TBL] [Abstract][Full Text] [Related]
16. De Novo Peptide and Protein Design Using Generative Adversarial Networks: An Update.
Lin E; Lin CH; Lane HY
J Chem Inf Model; 2022 Feb; 62(4):761-774. PubMed ID: 35128926
[TBL] [Abstract][Full Text] [Related]
17. Deep Convolutional Generative Adversarial Networks to Enhance Artificial Intelligence in Healthcare: A Skin Cancer Application.
La Salvia M; Torti E; Leon R; Fabelo H; Ortega S; Martinez-Vega B; Callico GM; Leporati F
Sensors (Basel); 2022 Aug; 22(16):. PubMed ID: 36015906
[TBL] [Abstract][Full Text] [Related]
18. Graph generative and adversarial strategy-enhanced node feature learning and self-calibrated pairwise attribute encoding for prediction of drug-related side effects.
Xuan P; Xu K; Cui H; Nakaguchi T; Zhang T
Front Pharmacol; 2023; 14():1257842. PubMed ID: 37731739
[No Abstract] [Full Text] [Related]
19. Exploring the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry.
Kao PY; Yang YC; Chiang WY; Hsiao JY; Cao Y; Aliper A; Ren F; Aspuru-Guzik A; Zhavoronkov A; Hsieh MH; Lin YC
J Chem Inf Model; 2023 Jun; 63(11):3307-3318. PubMed ID: 37171372
[TBL] [Abstract][Full Text] [Related]
20. Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular
Lin E; Lin CH; Lane HY
Molecules; 2020 Jul; 25(14):. PubMed ID: 32708785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
